SDGR
Schrödinger, Inc.Technology · $2.3B market cap
Verdict
We can't put a fair value on SDGR right now. Its earnings are too small compared with its share price for an earnings-based value to mean anything.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow SDGR
Track it on your watchlist and see the full analysis. Free.
Create a free accountSuperinvestors
1 of the investors we track holds SDGR. Who we track
About Schrödinger, Inc.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery…
Software - Application
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works